Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas

Corso, S; Pietrantonio, F; Apicella, M; Migliore, C; Conticelli, D; Petrelli, A; D'Errico, L; Durando, S; Moya-Rull, D; Bellomo, SE; Ughetto, S; Degiuli, M; Reddavid, R; Fumagalli, U; De Pascale, S; Sgroi, G; Rausa, E; Baiocchi, GL; Molfino, S; De Manzoni, G; Bencivenga, M; Siena, S; Sartore-Bianchi, A; Morano, F; Corallo, S; Prisciandaro, M; Di Bartolomeo, M; Gloghini, A; Marsoni, S; Sottile, A; Sapino, A; Marchio, C; Dahle-Smith, A; Miedzybrodzka, Z; Lee, J; Ali, SM; Ross, JS; Alexander, BM; Miller, VA; Petty, R; Schrock, AB; Giordano, S

Corso, S (corresponding author), Univ Torino, Dept Oncol, Turin, Italy.; Corso, S (corresponding author), FPO IRCCS, Candiolo Canc Inst, Turin, Italy.; Giordano, S (corresponding author), Univ Torino, Dept Oncol, Candiolo Canc Inst FPO, IRCCS, Sp 142, I-10060 Turin, Italy.

CLINICAL CANCER RESEARCH, 2021; 27 (11): 3126

Abstract

Purpose: Gastric and gastroesophageal adenocarcinomas represent the third leading cause of cancer mortality worldwide. Despite significant therapeutic......

Full Text Link